Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand name in India. The company offers range of specialties, including cardiac, dental, neuro, oncological, orthopedic, renal, reproductive, and robotic sciences, as well as gastroenterology and hepatology, heart and lung transplant, organ transplantation, mother and childcare, and pediatrics services. It focuses on accident, biochemistry, anesthesiology, bariatric surgery, andrology and infertility, arthroscopy, Alzheimer's, bone, joint center specialties, and others. In addition, the company provides medical procedures for aneurysm, ankle arthritis and total ankle replacement, anterior cervical discectomy and fusion surgery, anterior resection, aortic aneurysm, aortic stent graft, aortic valve replacement, arthroscopy, atrial septal defect, bariatric surgery, and others. Krishna Institute of Medical Sciences Limited was incorporated in 1973 and is based in Secunderabad, India.

Revenue projections:

Revenue projections for KIMS
Revenue projections for KIMS

With KIMS's revenues forecasted to be lower than last year's, investors are expected to be cautious. A decline in revenue typically harms the company's bottom line, reducing profitability and making investors less confident about the company's ability to sustain its financial health.

Financial Ratios:

currentRatio 0.000000
forwardPE 52.071507
debtToEquity 123.719000
earningsGrowth -0.401000
revenueGrowth 0.292000
grossMargins 0.595950
operatingMargins 0.120480
trailingEps 7.480000
forwardEps 13.299020

KIMS's elevated forward PE ratio indicates that the stock may face limited price growth and is at risk for a correction. Investors should consider this metric alongside other fundamentals to accurately assess the stock's valuation.
Krishna Institute of Medical Sciences Limited's high debt-to-equity ratio shows the company is significantly leveraged, relying heavily on debt financing. This raises the potential for increased financial risk, especially if the company's earnings or cash flow are negatively impacted.
KIMS's low earnings and revenue growth indicate potential profit shrinkage. This suggests that the company's financial performance may be weakening, raising concerns about its future profitability and overall business outlook.
KIMS's negative gross and operating margins suggest the company is not generating profit from either its production process or day-to-day operations. This could signal cost overruns or difficulties in maintaining revenue levels.
KIMS's forward EPS exceeding its trailing EPS means the company is expected to be more profitable this year than last. This suggests an upward trend in earnings, with forecasts indicating that KIMS's financial performance will improve in the current financial year.

Price projections:

Price projections for KIMS
Price projections for KIMS

The stock price of Krishna Institute of Medical Sciences Limited has frequently been close to the lower end of analysts' projections. This trend indicates potential struggles for the company in achieving the growth anticipated by the market.

Recommendation changes over time:

Recommendations trend for KIMS
Recommendations trend for KIMS


The recent buy bias from analysts suggests Krishna Institute of Medical Sciences Limited is seen as a strong investment, encouraging more investors to consider it. With this favorable sentiment, Krishna Institute of Medical Sciences Limited appears to be a reliable option for parking money, offering stability and long-term growth potential in the stock market.